Hefei, China · Founded 2019 · Privately Held (backing)
Developer of genetic modification technologies intended for therapeutic applications in ophthalmic disorders. Starry Gene is based in Hefei, China and was founded in 2019. Its last reported valuation was $11.9 million in Nov 2020. It has raised $4.5 million.
Last reported valuation
$11.9M
Oct 2026
Priced at
—
Total raised
$4.5M
Last round
—
Cap table — not yet on record
Starry Gene's share-class structure hasn't surfaced in our sources yet. Cap tables are assembled from certificates of incorporation, round filings, and disclosures as they land.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of Starry Gene with a free account
·Watch Starry Gene: the Monday email on marks, rounds and moves
